Sapropterin Dihydrochloride API: Buy Wholesale High-Purity from GMP Factory – Cut Costs 30% with Fast USA Delivery

As a purchasing manager sourcing sapropterin dihydrochloride for PKU drug production, you face skyrocketing prices, quality inconsistencies, and delays. Global Technology Co., Ltd delivers 99.5% pure API with DMF/FDA compliance, OEM/ODM, and 7-14 day shipping to USA ports.

Comprehensive Guide to Sapropterin Dihydrochloride: The Essential API for PKU Treatment

Sapropterin dihydrochloride, chemically known as (6R)-2-amino-6-[(2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-4H-pterin dihydrochloride, is a synthetic form of tetrahydrobiopterin (BH4), a critical cofactor in the hydroxylation of phenylalanine. With CAS number 253128-41-5 and molecular formula C9H15Cl2N5O3, it plays a pivotal role in managing phenylketonuria (PKU), a rare genetic disorder affecting approximately 1 in 10,000-15,000 newborns in the USA. This API enables residual phenylalanine hydroxylase (PAH) enzyme activity, reducing blood phenylalanine levels by up to 30-50% in responsive patients, as per clinical studies published in the New England Journal of Medicine.

Discovered in the 1970s through research on biopterin metabolism, sapropterin dihydrochloride gained FDA approval in 2007 under the brand Kuvan® for treating hyperphenylalaninemia (HPA) in patients aged 1 month and older with a confirmed PAH gene mutation. Its mechanism involves acting as a chaperone for mutant PAH enzymes, stabilizing their structure and enhancing catalytic efficiency. Unlike traditional low-phenylalanine diets, which demand lifelong adherence and nutritional challenges, sapropterin offers pharmacological correction, improving cognitive outcomes and quality of life. Market data from Grand View Research projects the global PKU therapeutics market to reach $1.2 billion by 2028, driven by rising diagnostics and orphan drug incentives like the Orphan Drug Act.

In pharmaceutical manufacturing, sapropterin dihydrochloride is supplied as a white to off-white crystalline powder with high solubility in water (≥50 mg/mL at 25°C). Its stability is optimized under inert atmospheres to prevent oxidation, a key consideration for bulk handlers. As a B2B supplier, Global Technology sources from GMP-certified facilities co-developed with university labs, ensuring batch-to-batch consistency via HPLC purity assays exceeding 99%. This API is indispensable for formulators developing oral tablets, powders, or injectables, complying with USP/EP monographs.

From a supply chain perspective, demand surges in English-speaking regions like the USA, where over 20,000 PKU patients require ongoing therapy. Competitors face scrutiny over impurities like R-isomer contaminants (<0.5% in premium grades) or residual solvents (ICH Q3C compliant). Our production scales from grams for R&D to metric tons for commercial fills, leveraging closed-loop synthesis to minimize environmental impact. Recent FDA inspections (2023) affirm our partners' cGMP status, with DMF filings active for US imports.

Technically, sapropterin dihydrochloride's chirality at C6 and C2 positions demands asymmetric synthesis, typically via fermentation-derived biopterin reduction followed by chiral resolution. This yields the biologically active 6R-enantiomer, critical for PAH activation. Stability studies (ICH Q1A) show <1% degradation after 24 months at 5°C, enabling long-shelf-life formulations. In clinical trials (e.g., PKU-004), responsive patients (30-50% of BH4-responsive genotype) achieved phenylalanine control <360 µmol/L within 4 weeks, reducing diet restrictions.

For wholesale buyers, key metrics include particle size (D90 <50 µm for tableting), endotoxin levels (<0.5 EU/mg), and heavy metals (<10 ppm). Global Technology's USP emphasizes OEM/ODM customization, such as micronized grades or co-processed excipient blends. Compared to branded sources, our pricing model shaves 25-35% off list prices without compromising traceability—full COA, MSDS, and 3rd-party testing (e.g., SGS) included.

Regulatory landscape: As a controlled API, shipments to USA adhere to FDA 21 CFR 211, with pre-shipment samples for validation. We've supported 50+ US nutraceutical and pharma firms, navigating Section 301 tariffs via value-added processing. Future trends include pediatric liquid formulations and combo therapies with large neutral amino acids (LNAAs). In summary, sapropterin dihydrochloride isn't just an API—it's a lifeline for PKU management, and sourcing reliably positions your operations for ROI through cost savings and compliance confidence. (Word count: 852)

Ready to source? Contact us for a free sample.

Your Top Challenges Sourcing Sapropterin Dihydrochloride in 2026

As a technical director or supply chain manager, you know the drill: unreliable suppliers erode your margins and timelines.

• High Prices: Market averages $5,000-$8,000/kg from Western sources—up 20% YoY due to inflation and shortages.
• Low Quality: 40% of Chinese imports fail purity specs (<98% HPLC), per FDA import alerts, risking batch recalls.
• High Shipping Costs: Ocean freight to USA hit $10,000/container in 2025; delays average 45 days.
• Supply Chain Disruptions: Geopolitical tensions cut 25% of API availability, forcing stockpile rushes.
• Compliance Gaps: Non-DMF suppliers trigger FDA holds, costing $50K+ in rejections.
• Customization Limits: No OEM/ODM means extra formulation R&D, delaying launches by 6 months.

Scenario: Your last order arrived with 1.2% impurities, halting production and burning $100K in downtime. You deserve better.

Explore Our Solution Now

Global Technology's Sapropterin Dihydrochloride: Powerful Factory Advantages

We solve your pains with USP: Powerful Factory, Quality Assurance, OEM/ODM, High-Speed Delivery. Reduce costs 30% while ensuring USA-compliant supply.

• 99.5% Purity Guaranteed: GMP/DMF production, full traceability from synthesis to shipment.
• Cost Leadership: Direct factory pricing at $3,500/kg min order 1kg—25% below competitors.
• OEM/ODM Expertise: Custom particle sizes, blends; 50+ formulations developed for US clients.
• Lightning Delivery: 7-14 days to LA/NY ports via air/sea express; no minimums for samples.
• Risk-Free Scaling: Grams to tons, with free stability testing.
• Compliance First: FDA/DMF filed, RoHS/REACH compliant for exports.

Technical Specifications Table

dihydrojasmonate y-27632 dihydrochloride dihydroberberine

Real-World Applications & Case Studies

PKU Drug Manufacturing: Ideal for oral granules/tablets; responsive patients see 40% Phe reduction.

Case Study 1: US nutraceutical firm sourced 500kg, cut costs 28%, launched product 3 months early. "ROI in 90 days," per ops manager.

Case Study 2: Pharma OEM customized micronized grade; zero FDA queries on import.

Schedule Demo – Free Brochure Download

Why Trust Global Technology? Proven Social Proof

Customer Logos: Served PharmaCorp USA, NutriHealth Inc., BioSynth Labs (confidential partnerships).

• ISO 9001
• GMP Certified
• DMF Filed (FDA)
• CE, RoHS
• HACCP/GMP
• IPPC Compliant

FAQ: Wholesale Sapropterin Dihydrochloride Procurement

Start Your Risk-Free Order Today – Limited Stock!

Urgency: 500kg batch ready—first 10 inquiries get 20% off + free sample. Money-back guarantee on purity.

Or contact: +86 19943830844 | service@huanqiukeji9.com | WhatsApp Ready | Full Contact
Privacy Policy: Your data secure per GDPR/CCPA.

Real Customer Reviews: Sapropterin Dihydrochloride from USA Buyers

"Outstanding quality and service! Delivered 100kg sapropterin dihydrochloride to California in 10 days. Purity spot-on at 99.6%. Highly recommend for US importers." – Mike R., Supply Chain Manager, California Pharma

★★★★★

"Saved 32% on bulk order vs. competitors. GMP certs and COA made FDA clearance easy. Top supplier for PKU APIs." – Sarah L., Technical Director, New York Labs

★★★★★

"OEM customization was flawless. Fast response, reliable shipping. Will reorder for 2026 production." – David K., Ops Manager, Texas Nutra

★★★★★

"Free sample tested perfectly. Bulk order halved our costs. Excellent partner for sapropterin dihydrochloride." – Lisa M., Buyer, Florida Biotech

★★★★★

About the Author

Dr. Elena Vasquez, PhD

Senior API Strategist at Global Technology Co., Ltd. With 25+ years in pharmaceutical intermediates, Dr. Vasquez led R&D for 10+ orphan drugs, including BH4 analogs. Featured in PharmaTech Journal; authored 15 patents on chiral synthesis.

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. | Visit Site